Overweight and obesity are highly prevalent conditions among working adults, with over 34% of the working population estimated to be overweight and close to 30% estimated to be obese.^[@R1]^ Excess body weight is associated with a host of chronic conditions, most notably Type 2 diabetes and cardiovascular disease.^[@R2]^ Obesity-related conditions among working adults are known to have significant economic impacts on employers through increased healthcare utilization costs, loss of worker productivity, and greater indemnity/worker\'s compensation claims.^[@R3]--[@R5]^ Weight loss through the adoption of healthful eating and physical activity patterns reliably reduces the risk of diabetes and improves intermediate risk factors for cardiovascular disease.^[@R6],[@R7]^ Given the health and economic burden of excess weight on working adults and their employers, successful strategies to induce weight loss, prevent weight gain, and prevent the onset of chronic disease can attenuate the negative consequences on health, worker productivity, and increased health care spending.

The Diabetes Prevention Program (DPP) is an evidence-based program focused on sustainable behavior changes to reduce weight among adults at risk for Type 2 diabetes.^[@R6]^ The DPP program model was originally developed for face-to-face implementation with regular, on-site meetings for weight-tracking, delivery of educational curriculum, and supportive discussion with a health coach or peer group.^[@R8]^ The DPP has been translated for worksite settings; these translations are becoming more frequent in workplaces with promising results for promoting healthful weight loss and chronic disease risk reduction.^[@R9]--[@R15]^ However, many employers have employees who telecommute or are dispersed in around-the-clock shifts and/or multiple geographic locations; these logistical complications pose barriers to traditional DPP translational programs that are delivered through in-person, place-based formats.

To meet the need for more flexible program offerings, technology-enhanced methods and digital health programs have emerged to translate the DPP into alternative formats.^[@R16]^ Digital health programs integrate components of mobile technology, the internet, wireless devices, social networks, health information technology, etc., to deliver more personalized and precise health care and more efficiently support and serve users. Digital programs allow users to engage through multiple communication channels (eg, mobile apps, internet, connected devices), are accessible to users around the clock, and remove the barriers of scheduling conflicts and logistical difficulties that can arise with place-based and time-bound programs. Digital health programs have been shown to improve the physical activity and eating behaviors of participants.^[@R17]--[@R19]^ These programs can be an effective mechanism for supporting goal-setting, self-monitoring, and providing feedback on performance regarding physical activity and dietary changes,^[@R20],[@R21]^ which are key components of DPP.

Concerns remain that digital programs may not succeed in engaging participants and achieving results in workplace settings, given the less familiar mode of program delivery and social environment relative to traditional, in-person worksite DPP programs. The purpose of this study was to examine the participation and diabetes risk factor-related outcomes of a digital diabetes prevention program during the first year it was offered to a workforce. It was hypothesized that employees and dependents who enrolled in the program would show substantial engagement in the online and digital content and achieve meaningful reduction in risk factors for Type 2 diabetes, as evidenced by reduced weight and fasting blood glucose. The secondary hypothesis was that the program participants would have corresponding improvements in health behaviors (nutrition and physical activity), and reductions in intermediate risk factors for cardiovascular disease.

METHODS
=======

Design
------

The study employed a nonequivalent (ie, non-randomized) design with a matched control group. Data were collected annually for the workforce from 2013 through 2015, with 2014 to 2015 being the intervention year. Only those employees who had participated in the annual assessments in 2014 and 2015 were included in the primary analyses. The study was approved by Western Institutional Review Board.

Setting and Participants
------------------------

Iron Mountain, Incorporated is a global storage and information management services company with headquarters in Boston, MA. The company offers services for records and document management, data management, data centers, art storage and logistics, and secure document destruction services through a network of 1,400 locations in 46 countries. The company employs 25,000 people worldwide, with 8800 employees in the United States spread across 44 states. The average United States employee is 43 years old, with an average company tenure of 8.5 years. However, the proportion of long-service employees continues to grow, resulting in the need for long-term health and wellness solutions. In 2013, 29% of the workforce had been employees for 10 years or longer. By January, 2017, 40% of the workforce had 10 years or longer tenure. The majority of employees (74%) are men. The workforce spans several job categories and includes truck drivers, record center specialists, consultants, data center technicians, sales and customer service representatives, and corporate service providers.

All US-based employees and their spouses/domestic partners (if covered on Iron Mountain\'s health plans) were offered the opportunity to participate in the digital diabetes prevention program if they were determined to be eligible. Program eligibility requirements included: 18 years of age or older; body mass index (BMI) greater than or equal to 24 kg/m^2^ (or 22 kg/m^2^ if the person endorses Asian racial identity); able to engage in light physical activity; and at risk for diabetes as evidenced by (a) a blood-based laboratory test in the prediabetic range (fasting blood glucose 100 to 125 mg/dL, hemoglobin A1c 5.7% to 6.4%, or oral glucose tolerance test 140 to 199 mg/dL), or (b) self-reported diagnosis of prediabetes or previous diagnosis of gestational diabetes, or (c) elevated score on a diabetes risk screener.^[@R22]^ Participants were excluded based on the following criteria: already diagnosed with Type 1 or 2 diabetes; on a medically prescribed diet; under treatment for an acute medical/psychiatric condition that would prohibit full participation; currently pregnant or planning to become pregnant; and scheduled for bariatric surgery or recently had bariatric surgery.

INTERVENTION
============

The Omada Health Program^®^ is a digital adaptation of the DPP lifestyle intervention using its own proprietary curriculum.^[@R23]^ The program consisted of small group support, personalized health coaching, a weekly behavior change curriculum approved by the diabetes prevention recognition program,^[@R24]^ and various online tools, mobile tools, and wireless devices to track eating patterns, physical activity, and body weight. Participants were matched into geographically similar small groups and connected through a private online social network where they could discuss goal progress and provide social support to one another. Trained health coaches were assigned to each group for the duration of the program. The coaches were responsible for monitoring participant progress and lesson completion, and facilitating group discussions. The program allowed participants to asynchronously complete weekly lessons through an online or mobile platform, privately communicate via phone, text, email, or private message with their health coach for individual counseling, track weight loss and physical activity using a wireless weight scale and activity tracker, and view their weight loss progress on any laptop, tablet, or smartphone. The program started with a 16-week curriculum similar to the original DPP, with one new lesson released each week. After the first 16 weeks, the program continued with 36 weeks of additional weekly curriculum lessons focused on the reinforcement of healthful habits, weight maintenance, and relapse prevention.

MEASURES
========

As part of the organization\'s employee health and wellness program LiveWell, employees voluntarily completed annual biometric and health risk assessments. These annual measurements served as the basis for the outcome measures.

Annual Biometric Assessments
----------------------------

A corporate wellness provider (ADURO, Inc., Redmond, WA) provided annual biometric assessments and health risk appraisals for the workforce to evaluate clinically valid risk factors for Type 2 diabetes and cardiovascular disease. All tests were administered either at the worksite by an ADURO health professional, by a health care provider at a physician\'s office, or at a contracted medical laboratory facility. The ADURO staff are required to receive internal certification, complete best-practice guideline training and annual competency reviews, and have a current license as either a phlebotomist, medical assistant, licensed practical nurse, vocational nurse, registered nurse, or nurse practitioner.

### Anthropometric Measurements

Body weight was measured under fasting conditions, stocking feet, and light clothing using a Health o Meter Professional Digital Floor Scale (model 800KL, Pelstar LLC, McCook, IL), which measures weight up to 400 pounds. Participants weighing more than 400 lbs were recorded as 400 lbs and noted in the system as weight more than 400 lbs. Height was measured using a calibrated stadiometer with the subject in stocking feet. Waist circumference was measured using a 72-inch cloth measuring tape at the umbilical line over clothing.

### Blood Pressure

Blood pressure was measured with a manual sphygmomanometer and stethoscope and with the participant seated in a resting state.

### Blood Glucose and Lipids

Participants provided a blood sample via fingerstick to obtain fasting blood glucose and blood lipid measurements. Participants were instructed to fast for 8 hours prior to giving the sample. The fingerstick glucose measure was analyzed using the Cholestech LDX^®^ System (Alere Inc., Waltham, MA). The lipid panel quantified total cholesterol, high-density lipoprotein (HDL), estimated low-density lipoprotein (LDL), and triglycerides, also using the Cholestech LDX^®^.

### Self-report Health Risk Appraisal

Health risk appraisals (HRA) were completed by employees using a validated and reliable survey system (Limeade^®^, Bellevue, WA) that assesses psychological health, well-being, health behaviors or habits, and perceived workplace productivity. The 107 items on the instrument are rated on a scale of 1 to 5, with higher scores indicating better health or health behavior patterns. A summary score and subscores are calculated by taking the combined average of relevant items clustered in different well-being dimensions, including physical activity level, healthful nutritional intake, overall health, and well-being. Cronbach α for subscales range from 0.56 to 0.97 for the various dimensions.^[@R25]^ The assessment was administered via the online survey tool through the employer\'s organizational wellness platform.

### Program Participation

The digital health program software platform captured completion of curriculum lessons (paced at a weekly frequency) and weigh-ins on the wirelessly connected scale, which recorded weights every time the participant stepped on the scale. Each curriculum lesson was given a score of 0 (zero) if it was not completed during a week, or 1 if the lesson was completed.

ANALYSIS PLAN
=============

Data Preparation
----------------

The data were merged from three sources: biometric assessments, the self-reported HRA, and program weight and lesson completion data. Of the 829 participants who began the Omada program, 764 could be linked to HRA/biometric data from 2013, 2014, or 2015. Of these 764 IDs, 634 had records in either or both of the HRA and biometric datasets for both 2014 and 2015. Because changes in risk factors from 2014 to 2015 were of primary interest, 634 Omada participants were retained for the primary analyses.

For the 7,026 people with data from 2014 to 2015 in one or both of the Aduro datasets, approximately 9.7% of data were missing across 42 variables, with the degree of missingness per variable ranging from 0% to 33%. We carried out 10 imputations of missing data using the R package Amelia II.^[@R26]^ Given a missing datum for person *i*, variable *j*, and year *k*, Amelia makes imputations on the basis of (a) data from person *i* and year *k*, for variables other than *j*, as well as (b) data from person *i* and variable *j* for years other than *k*. For the across-time imputations (b), we set Amelia to use data from 2013 where available and to fit polynomials of order 2 for making predictions. We set Amelia\'s empirical ridge parameter to 4% of the number of rows in the dataset, and we set variables with discrete data to be ordinal.

Identifying Matched Comparison Participants
-------------------------------------------

The R package Matchit^[@R27],[@R28]^ was used to identify a matched sample for comparison with program participants. Though employees selected for the matching did not participate in Omada, they may have been eligible for other health and wellness benefits from the employer. The sample was matched on age, sex, and employee/dependent status, as well as on pretreatment (data from 2014) body mass index, total cholesterol, LDL cholesterol, systolic and diastolic blood pressure, fasting blood glucose, triglycerides, and waist circumference. We identified a comparison sample matched on these covariates that was twice as large as the Omada sample (*n* = 634 × 2 = 1268). The matching was performed in one of the 10 imputed datasets, but the identified sample matched the Omada participants well in all 10 datasets. Across all 10 imputed datasets, the two groups did not differ on any of the 11 covariates (Wilcoxon *P*s \> 0.19). The largest standardized difference between Omada and comparison cases across the 10 imputed datasets (where "standardized difference" indicates mean difference divided by standard deviation in the control group) was 0.074.

Analytic Strategy
-----------------

Primary outcomes included changes in weight, BMI, and fasting blood glucose from the year prior to commencement of the program to the year following the program. Secondary outcomes included changes in blood pressure, lipids, waist circumference, health behaviors, and perceived health over the same period of time. For our main analyses, we used generalized estimating equations (GEEs) as implemented in the R package gee, which can account for correlations among observations from the same person at different times. We used an exchangeable covariance matrix and robust Huber-White standard errors. For primary analyses (BMI, fasting blood glucose, and weight), we compared GEE results with those of linear mixed models. The results were found to be entirely parallel, so we report only the GEE results. Analyses were completed in all 10 imputed datasets and pooled using Rubin\'s rules.^[@R29],[@R30]^

Results
-------

A total of 963 people completed the enrollment process, of which 829 (86.0%) began the program. Of the participants who enrolled in the digital health program, 58.4% were women and 68% were white, 14% were black/African American, and 9% were Latino. Participants ranged in age from 23 to 68 years old, with a median age of 46 years. The average initial BMI of the workforce was 34.5 kg/m^2^, which was in the obese category (BMI is more than 30). Average waist circumference was in the high risk range (waist circumference is more than 105 cm for men and more than 88 cm for women^[@R31]^). The average resting blood pressure, fasting blood glucose, and lipids levels were within normal limits (see preintervention values on Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}). When the sample was examined for those with risk factor elevations consistent with prediabetes and metabolic syndrome,^[@R32],[@R33]^ approximately 22% had fasting blood glucose more than 100 mg/dL; 31% of the sample had systolic blood pressure more than 130 mmHg; 25% had diastolic blood pressure more than 85 mmHg; 37% of the sample had total cholesterol more than 200 mg/dL; 38% had triglycerides more than 150 mg/dL; 48% of men and 44% of women had low HDL cholesterol (less than 40 mg/dL for men, less than 50 mg/dL for women).

### Program Participation

Across all program enrollees, a total of 775 participants (94.2%) completed at least four curriculum lessons during the intensive phase of the program (ie, the first 16 weeks), and 685 participants (82.6%) completed at least nine lessons. On average, participants completed 19.7 lessons over the course of the year.

### Biometric and Self-report Health Risk Appraisal

Of the 829 participants in the program, 634 had a sufficient biometric or self-report data for analysis. The matched comparison group was constructed from 1,268 employees and dependents who did not participate in the intervention. As illustrated in Fig. [1](#F1){ref-type="fig"}, the average weight in the workforce increased by approximately 3.5 pounds from 2013 to 2014. From 2014 to 2015 when the program was underway, those who participated in the intervention did not continue to gain weight. The average weight in the non-treated comparison group increased by approximately a pound. Adjusting for age and sex, the pre-post difference in weight was significantly different by group (*β* = −3.4 lbs, standard error \[SE\] = 1.4 lbs, Wald *Z* = 2.5, *P* = 0.01), with comparison group gaining more weight relative to the intervention group\'s trajectory. A total of 31% of Omada participants lost at least 5% of their starting body weight, compared with 20% of controls (adjusting for age, sex, and baseline weight, logistic *β* = 0.59, SE = 0.13, *t* = 4.6, *P* = 0.001, see Fig. [2](#F2){ref-type="fig"}). Approximately, 22% of intervention participants dropped one or more BMI category (ie, from overweight to normal weight, or from obese to overweight, etc.), compared with 15% of matched controls, which was significant after adjusting for age, sex, and baseline BMI (logistic *β* = 0.48, SE = 0.14, *t* = 3.4, *P* = 0.001). Program participants experienced an average reduction of 1.49 mg/dL in fasting blood glucose, whereas controls had an increase of 1.15 mg/dL (adjusting for age and sex, *β* = −2.6, SE = 1.1, Wald *Z* = −2.4, *P* = 0.02).

![Trends in weight gain and loss year by year.](joem-59-e150-g001){#F1}

![Percent weight change from 2014 to 2015.](joem-59-e150-g002){#F2}

There were no significant differences between controls and intervention participants in the change from pre- to post-treatment measures for systolic and diastolic blood pressure, total cholesterol, LDL, HDL, or triglycerides. Though not statistically significant, waist circumference decreased by 1 cm in participants and increased by 0.2 cm in controls (adjusting for age and sex, *β* = −0.49, SE = 0.26, Wald *Z* = −1.85, *P* = 0.06). Participants improved their nutritional intake score by 0.16 points, compared with a smaller increase of 0.03 points in controls (adjusting for age and sex, *β* = 0.13, SE = 0.03, Wald *Z* = 4.0, *P* = 0.001).

Post Hoc Analyses
-----------------

Among Omada program participants, we evaluated whether weight loss (as assessed by the difference between participants' first and last weigh-in on the Omada scale) was associated with changes in other biometric or HRA measures. As measured by the Omada scale, program participants lost on average 4.6% (SD = 5.0%) of initial body weight at 16 weeks. After adjusting for age and sex, weight loss was associated with decreases in total cholesterol (*β* = 0.41, SE = 0.11, Wald *Z* = 3.6, *P* = 0.001), LDL (*β* = 0.27, SE = 0.10, Wald *Z* = 2.7, *P* = 0.001), and triglycerides (*β* = 0.75, SE = 0.32, Wald *Z* = 2.4, *P* = 0.02); no associations were detected with other risk factors.

The Diabetes Prevention Recognition Program emphasizes a goal for participants to complete at least 9 of the weekly curriculum lessons during the intensive phase of the program.^[@R34]^ With this in mind, we conducted post-hoc analyses of those who completed at least 9 of 16 lessons (completers) compared with those who completed fewer than 9 lessons (non-completers). In general, program completers (*n* = 540) had better outcomes than non-completers (*n* = 94). Completers lost more weight (*β* = 8.2, SE = 2.4, Wald *Z* = 3.4, *P* = 0.001) and reduced waist circumference (*β* = 1.5, SE = 0.5, Wald *Z* = 2.9, *P* = 0.004) more than non-completers, and experienced better improvements in nutrition (*β* = 0.32, SE = 0.08, Wald *Z* = 3.8, *P* = 0.001) and exercise (*β* = 0.27, SE = 0.08, Wald *Z* = 3.2, *P* = 0.001).

DISCUSSION
==========

Overall, the digital health program was effective at reducing the risk factors for diabetes and cardiovascular disease by reducing weight and blood glucose in this workforce sample. Participants in the intervention program lost a significant amount of body weight, while non-participants continued to gain weight. Though the observed decreases in fasting blood glucose levels and waist circumference were modest among program participants, all measures moved in the desired direction and were indicative of progress towards better health and reduced risk. Additionally, a significant percentage (30%) of program participants lost a meaningful amount of weight (\>5%, according to the Diabetes Prevention Recognition Program Standards).^[@R34]^ The comparison group\'s year after year weight differences indicated more weight gain relative to the intervention group. Both weight loss and prevention of weight gain are important objectives for diabetes risk reduction,^[@R35]^ and thus these findings help to validate the effectiveness of the program in inducing weight loss and preventing weight gain.

The majority of program participants (85%) completed the bulk of the program curriculum lessons. This level of engagement suggests that digital and mobile platforms are a feasible and accessible method for receipt of intensive behavioral counseling services among a diverse and dispersed workforce. The finding that greater program engagement was related to greater changes in the targeted health behaviors (diet and exercise) lends further credibility, as people transformed their learnings into expected behavior changes. Taken together, these results provide further support for the application of digital behavior change programs for workforce chronic disease prevention.

Even the most committed organizations have limitations on the number of health professionals that can be employed to drive wellness efforts. The problem is magnified in large organizations with multiple worksites, telecommuting employees, traveling employees, and off-site employees. Organizations are looking for the best way to maximize their resources while reaching the largest number of employees possible. Digital health programs provide the needed flexibility to simultaneously enroll a large number of employees without encountering scheduling issues or other logistical obstacles, making the digital format a promising solution to increase the reach of health promotion programs. Digital programs also have the benefit of being easy to implement. These factors are critical to the adoption and continued use of the programs.

Though the study findings are encouraging, the results should be interpreted with caution. All employees throughout the workforce had access to additional corporate-sponsored wellness programs during the 2014 to 2015 time frame. This may have affected the magnitude of the studied program\'s effects. Participation in other programs by the comparison group members may have concealed some between-group differences. The study sample consisted of individuals who self-selected into the digital health program, which could bias the sample towards better outcomes. However, this was an observational study of how corporate wellness and risk reduction programs operate under ecologically valid conditions, with employees exercising freedom to opt into programs that may benefit them. Whereas the non-randomized, non-controlled setting in which this study took place limits causal inference, it may reflect the real-world implications and outcomes of offering an online diabetes prevention program in a workplace. The use of a matched control group also provided an indicator of natural trends in the workforce over time. Further research is needed to determine the effects of these programs on long-term outcomes, such as health care utilization and organizational costs. Despite these limitations, the program participants successfully made meaningful lifestyle changes to reduce the risk of chronic disease through weight loss, prevention of weight gain, improved glucose control, and better nutritional intake.

In conclusion, this study provides encouraging evidence that digital lifestyle intervention programs can be successfully delivered in worksite settings, and can achieve results in chronic disease risk factor reduction via weight loss, prevention of weight gain, and improved biometric indicators. These findings support the feasibility of utilizing digital health programs in the workplace, and should encourage expanded use of digital health formats in workplaces with dispersed and mobile members. Effective options for scalable and flexible chronic disease prevention programs will give greater choice and access to workers, and help to improve the health of workforces. Future research will be able to examine the long-term impact of programs on subsequent delay of disease onset or progression, and eventual changes in health care utilization, workplace productivity, and related long-term outcomes.
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###### 

Changes in the Primary Outcomes Before and After the Intervention

  Variable                        Preintervention Estimate (SE)              Postintervention Estimate (SE)   Intervention-Control Difference in Trajectory Estimate (SE)
  ------------------------------- ------------------------------------------ -------------------------------- -------------------------------------------------------------
  Weight (pounds)                                                                                             
   Intervention group             215.7 (1.9)                                213.7 (1.9)                      −3.4 (1.4)[^\*^](#TF1-1){ref-type="table-fn"}
   Control group                  214.8 (1.6)                                216.1 (1.6)                      
  BMI (kg/m^2^)                                                                                               
   Intervention group             33.9 (0.3)                                 33.4 (0.3)                       −0.60 (0.18)[^\*\*^](#TF1-2){ref-type="table-fn"}
   Control group                  33.7 (0.2)                                 33.9 (0.2)                       
  Fasting blood glucose (mg/dL)                                                                               
   Intervention group             95.2 (1.0)                                 93.7 (0.9)                       −2.6 (1.1)[^\*^](#TF1-1){ref-type="table-fn"}
   Control group                  96.4 (0.8)                                 97.5 (0.8)                       
  Reduction in BMI category (%)                                                                               
   Intervention group             22%[^\*\*^](#TF1-2){ref-type="table-fn"}                                    
   Control group                  15%                                                                         

Estimates combined from 10 generalized estimating equations (GEE) fitted to multiple imputed datasets. Models adjusted for age and sex, which were mean-centered.

BMI, body mass index; SE, standard error.

^\*^*P* = 0.05.

^\*\*^*P* = 0.001.

###### 

Changes in the Secondary Outcomes Before and After the Intervention

  Variable                                                                    Intervention Group Mean (SE)   Control Group Mean (SE)
  --------------------------------------------------------------- ----------- ------------------------------ -------------------------
  Systolic BP (mmHg)                                              Pretest     122.9 (0.6)                    123.2 (0.4)
                                                                  Post-test   124.2 (0.6)                    124.3 (0.4)
  Diastolic BP (mmHg)                                             Pretest     79.3 (0.4)                     79.3 (0.3)
                                                                  Post-test   79.4 (0.4)                     79.2 (0.3)
  Total cholesterol (mg/dL)                                       Pretest     191.0 (1.5)                    191.0 (1.1)
                                                                  Post-test   186.4 (1.5)                    188.7 (1.1)
  HDL cholesterol (mg/dL)                                         Pretest     48.2 (0.5)                     49.4 (0.4)
                                                                  Post-test   48.2 (0.5)                     49.0 (0.4)
  Triglycerides (mg/dL)                                           Pretest     145.8 (3.6)                    147.5 (3.0)
                                                                  Post-test   139.9 (4.0)                    143.0 (2.5)
  Waist circumference[^\*\*^](#TF2-2){ref-type="table-fn"} (cm)                                              
   Women                                                          Pretest     100.3 (0.8)                    99.6 (0.8)
                                                                  Post-test   99.3 (1.0)                     99.8 (0.8)
   Men                                                            Pretest     105.7 (1.0)                    106.7 (0.8)
                                                                  Post-test   104.6 (1.0)                    106.9 (0.8)
  Overall health                                                  Pretest     2.89 (0.03)                    2.74 (0.03)
                                                                  Post-test   2.86 (0.03)                    2.75 (0.03)
  Overall physical condition                                      Pretest     3.76 (0.01)                    3.76 (0.01)
                                                                  Post-test   3.77 (0.01)                    3.76 (0.01)
  Nutrition[^\*^](#TF2-1){ref-type="table-fn"}                    Pretest     3.72 (0.03)                    3.80 (0.02)
                                                                  Post-test   3.88 (0.03)                    3.83 (0.02)
  Exercise and fitness                                            Pretest     3.42 (0.03)                    3.48 (0.02)
                                                                  Post-test   3.47 (0.03)                    3.47 (0.02)

Estimates combined from 10 generalized estimating equations (GEE) fitted to multiple imputed datasets. Models adjusted for age and sex, which were mean-centered.

BMI, body mass index; SE, standard error.

^\*^*P* = .0.001.

^\*\*^*P* = 0.09.
